AIとIPFと癒しの音楽

特発性肺線維症 idiopathic pulmonary fibrosis (IPF)患者によるIPF関連学術情報の収集とシェア。癒しの音楽もお届けしています。

IPF Weekly Update

ChatGPTを活用して業務のAI化を進めています。プロンプトエンジニアリングの専門家です!と、名乗れるレベルではありませんが、かなり色々使いこなしてきています。この1年、病気で失われた能力は、別な能力を発達させる、進化することで生き残っていこうと思います。

<><><>

23/13/30

 

Deciphering the role of fibrosis-specific alveolar basal cells in idiopathic pulmonary fibrosis

S Blumer - 2023

… Their precise role in IPF is incompletely understood; some studies suggest a regenerative potential in animal models, while others … towards innovative therapeutic approaches for IPF patients. While the increased presence of alveolar …

  • 特発性肺線維症における線維症特異的な肺胞基底細胞の役割の解読 



Neural Network Based Methods for the Survival Analysis of Idiopathic Pulmonary Fibrosis Patients from a Baseline CT Acquisition

AC Whitehead, AH Shahin, A Zhao, DC Alexander… - 2023 IEEE Nuclear Science …, 2023

… Neural Network Based Methods for the Survival Analysis of Idiopathic PulmonaryFibrosis Patients from a Baseline CT Acquisition Abstract: Idiopathic pulmonary fibrosis is an interstitial lung disease that causes scarring of the lungs, leading to a …



Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases

T Isshiki, S Naiel, M Vierhout, K Otsubo, P Ali… - Pharmacology & …, 2023

… The treatment of interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF), remains … in IPF and other pulmonary fibrotic conditions. This review provides a comprehensive overview of the current evidence on the pathogenic role of CTGF in …

  • 線維性肺疾患における結合組織成長因子を標的とする治療戦略



[PDF] YTHDC1 delays cellular senescence and pulmonary fibrosis by activating ATR in an m6A-independent manner

C Zhang, L Chen, C Xie, F Wang, J Wang, H Zhou… - The EMBO Journal, 2023

… Accumulation of DNA damage in the lung induces cellular senescence and promotes age-related diseases such as idiopathic pulmonary fibrosis (IPF). Hence, understanding the mechanistic regulation of DNA damage repair is important for anti-aging …

  • YTHDC1はm6A非依存的にATRを活性化することで細胞老化と肺線維症を遅らせる



Anti-mutated citrullinated vimentin antibodies are increased in IPF patients

T Coralie, L Cédric, D Marie-Pierre, NR Pascale… - Respiratory Medicine and …, 2023

… : An increased prevalence of serum anti-MCV antibody is observed in the serum of patients with idiopathic pulmonary fibrosis (IPF) but the … Idiopathic pulmonary fibrosis (IPF) is a chronic and severe pathology characterized by progressive

  • IPF患者では抗変異シトルリン化ビメンチン抗体が増加している



[PDF] 特発性肺線維症をもつ人々の尊厳に着目したケア (ディグニティ・センタード・ケア) と基盤理論の開発

猪飼やす子 - 日本呼吸ケア・リハビリテーション学会誌, 2023

… 線維症(IPF; idiopathic pulmonary fibrosis)療養者の 生活の質は,低い傾向にあると 国内外の研究で報告されている.各国の呼吸器学会の IPF合同… 筆者は,特発性肺線維症 (idiopathicpulmonary fibrosis; IPF)の予後と生活の質に関心をもち,看護実践の開発 研究 …




[PDF] Navigating Compassion: A Comprehensive Review of Palliative Care in Respiratory Medicine

U Jadhav, J Bhanushali, A Sindhu, BSK Reddy… - Cureus, 2023

… The significance of integrating palliative care into the fabric of respiratory medicine lies in its ability to enhance the quality of life for patients facing the challenges of diseases, such as chronic obstructive pulmonary disease (COPD) …

  • 思いやりをナビゲートする: 呼吸器内科における緩和ケアの包括的なレビュー



[PDF] Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6

K Höhne, A Wagenknecht, C Maier, P Engelhard… - 2023

… Fibrogenesis is a key pathomechanism in various pulmonary diseases, particularly idiopathic pulmonary fibrosis (IPF) [1–3] and non-specific interstitial pneumonia (NSIP); but occurs also in endstage disease lungs of patients with …

  • ヒト肺線維芽細胞に対するCCL18の線維化促進効果はCCR6を介して媒介



23/12/28

 

External validation of Fibresolve, a machine-learning algorithm, to non-invasively diagnose idiopathic pulmonary fibrosis

J Bradley, J Huang, A Kalra, J Reicher - The American Journal of the Medical …, 2023

Idiopathic pulmonary fibrosis (IPF) is the most common subtype of interstitial lung disease (ILD). Establishing a diagnosis early is critical … to a pulmonary specialist despite the increased awareness of IPF. Delays in diagnosis of IPFresult in a high …



Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung

P Yan, J Liu, Z Li, J Wang, Z Zhu, L Wang, G Yu - International Journal of Molecular …, 2024

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by excessive deposition of fibrotic connective tissue in the lungs. Emerging evidence suggests that metabolic alterations, particularly glycolysis …

  • 特発性肺線維症における解糖系の再プログラミング: 肺における乳酸の謎を解明



PCR34 The Humanistic and Economic Burden of Illness in Progressive Fibrosing Idiopathic Lung Disease: A Targeted Literature Review

IG Jozsa, MCP Penaloza, Z Marjenberg - Value in Health, 2023

Progressive fibrosing lung diseases (PF-ILDs), including idiopathic pulmonary fibrosis(IPF), share common pathophysiologic characteristics … targeted literature review aims to identify the humanistic (health-related quality of life [HRQoL]) and …

  • 進行性線維化性特発性肺疾患における病気の人文的および経済的負担: 対象を絞った文献レビュー 特発性肺線維症 (IPF) およびその他の間質性肺疾患 (ILD) における持続的な咳の負担: 体系的な証拠の総合



PCR253 The Burden of Persistent Cough in Idiopathic Pulmonary Fibrosis (IPF) and Other Interstitial Lung Diseases (ILD): A Systematic Evidence Synthesis

R Green, M Baldwin, N Pooley, M Rutten-van Mölken… - Value in Health, 2023

… As cough remains a challenging symptom of IPF and other ILDs, we aimed to synthesise … Ten studies; 6 in IPF (n=271 patients), 2 in ILDs including IPF (n=294 patients), 1 in CTD-ILD (… /HRQoL measures, including three trials in IPFwhere …

  • 特発性肺線維症 (IPF) およびその他の間質性肺疾患 (ILD) における持続的な咳の負担: 体系的な証拠の総合 新型コロナウイルス感染症後および特発性肺線維症における単球とT細胞の高次元比較



High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis

GC Bingham, L Muehling, C Li, Y Huang, SF Ma… - Frontiers in Immunology

… Up to 30% of hospitalized COVID-19 patients experience persistent sequelae, including pulmonary fibrosis (PF). We examined COVID-19 … lung diseases, we analyzed samples from Idiopathic Pulmonary Fibrosis (IPF) patients. IPF patients …

 

  



Unraveling the mechanism of ethyl acetate extract from Prismatomeris connata YZ Ruan root in treating pulmonary fibrosis: insights from bioinformatics, network …

S Li, G Hu, L Kuang, T Zhou, H Jiang, F Pang, J Li… - Frontiers in Immunology

… The pathogenesis of this disease, especiallyparticularly idiopathic pulmonaryfibrosis (IPF), is still remains unknown. … -induced pulmonary fibrosis in mice, we confirmed the importance of macrophage polarization in IPF. The analysis revealed …

  • 肺線維症の治療における Prismatomeris connata Y. Z. Ruan の根からの酢酸エチル抽出物のメカニズムの解明: バイオインフォマティクス、ネットワーク薬理学、および実験的検証からの洞察  




Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data.

R Dinparastisaleh, A Vaezi, D Bandyopadhyay… - Annals of the American …, 2023

… We also studied two other sub cohorts of idiopathic pulmonary fibrosis (IPF) and non-IPF under the second cohort. Propensity score matching (PSM) was employed to match confounders between groups. The Kaplan Meier log rank test was applied …

 

 

 

23/12/26

 

[HTML] The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis: An overview of systematic reviews

S Song, Z Feng, W Liu, J Li - PloS one, 2023

… The role of pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) has been studied in several systematic reviews (SRs), but no … This overview aims to determine the effectiveness of PR in patients with IPF and to summarize and …



[HTML] … randomization analysis suggests no causal influence of gastroesophageal reflux disease on the susceptibility and prognosis of idiopathic pulmonary fibrosis

D Sun, Q Ye - BMC Pulmonary Medicine, 2023

… (GERD) and the susceptibility as well as the prognosis of idiopathic pulmonary fibrosis(IPF) has been previously suggested, with the potential … randomization (MR) study to investigate the causal effects of GERD on the susceptibility and prognosis of …

  • メンデルランダム化分析は、特発性肺線維症の感受性と予後に対する胃食道逆流症の因果関係がないことを示唆  



[PDF] Adenine Nucleotide Translocases and Cellular Senescence in Idiopathic Pulmonary Fibrosis

T Kobayashi, H Fujimoto, CN D'Alessandro-Gabazza… - American Journal of …, 2023

… of idiopathic pulmonary fibrosis (IPF) (2). We want to congratulate the authors for their excellent work. The authors found that ANT1 and ANT2 expression was significantly reduced in the lung tissue of IPF … Undoubtedly, these new insights …

  • 特発性肺線維症におけるアデニンヌクレオチドトランスロカーゼと細胞老化   



[HTML] S100 Calcium-Binding Protein A9, A Potential Novel Diagnostic Biomarker for Idiopathic Pulmonary Fibrosis

JU Lee, MK Kim, MS Kim, SJ Lee, S Park, HS Chang… - Journal of Korean Medical …, 2023

… is a characteristic feature of idiopathicpulmonary fibrosis (IPF). S100 calcium-binding protein A9 (S100A9) is a neutrophil-derived protein involved in the development of neutrophil-related chronic inflammatory disorders. However, the role of S100A9 in …

  • カルシウム結合タンパク質 A9、特発性肺線維症の新規診断バイオマーカーの可能性 




Air pollution exposure and its effects on idiopathic pulmonary fibrosis: clinical worsening, lung function decline, and radiological deterioration

P Mariscal-Aguilar, L Gómez-Carrera, G Bonilla… - Frontiers in Public Health

… known in idiopathic pulmonary fibrosis(IPF).Aim: This study aimed to investigate the effects of air pollution on clinical worsening, lung function, and radiological deterioration in patients with IPF.Methods: This exploratory retrospective cohort …

  • 大気汚染への曝露と特発性肺線維症への影響:臨床症状の悪化、肺機能の低下、放射線学的悪化   



[HTML] The Therapeutic Landscape in Chronic Cough

JA Smith - Lung, 2023

… refractory chronic cough and cough in idiopathic pulmonary fibrosis, as well as compounds previously explored. … is idiopathicpulmonary fibrosis where a significant subgroup of patients suffer chronic coughing alongside progressive

  • 慢性咳嗽の治療風景 



Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis

M Wijsenbeek, JJ Swigris, Y Inoue, M Kreuter… - The European respiratory journal

… and impact of pulmonary fibrosis in patients with progressive pulmonary fibrosis (PPF) in the INBUILD trial using the Living with Pulmonary Fibrosis (L-PF) questionnaire.Patients had a fibrosing interstitial lung disease (ILD) (other than idiopathicpulmonary fibrosis) …

  • 進行性肺線維症患者の症状に対するニンテダニブの効果  



Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data

A Vaeli Zadeh, R Dinparastisaleh, A Vaezi… - Annals of the American …, 2023

… We also studied two other sub cohorts of idiopathic pulmonary fibrosis (IPF) and non-IPF under the second cohort. Propensity score matching (PSM) was employed to match confounders between groups. The Kaplan Meier log rank test was applied …



[PDF] Advances in Diagnostics and Management of Respiratory System Diseases

P Confalonieri, F Salton, M Confalonieri, R Pozzan… - Diagnostics, 2024

… ) in predicting clinical evolution and prognosis in patients with idiopathic pulmonary fibrosis(IPF) [6]. The researchers enrolled 18 IPF p-ANCA-positive patients and 36 IPF p-ANCA-negative patients. Half of the IPF patients with p-ANCA …

  • 呼吸器系疾患の診断と管理の進歩 



 

<><><>

 

特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。

当面、毎週アラートの内容をアップしていこうと思います。

 

癒しの音楽をお届けいたします。 

youtu.be

###